Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 21, 2023
December 21, 2023
0146d188-0350-4f83-b103-4193b8be1e41
Related Documents
Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates: Guidance for Industry
Guidance DocumentSeptember 8, 2026Center for Drug Evaluation and Research
Reformulating Drug Products That Contain Carbomers Manufactured With Benzene
Guidance DocumentDecember 28, 2023Center for Drug Evaluation and Research
COVID-19: Developing Drugs and Biological Products for Treatment or Prevention: Guidance for Industry
Guidance DocumentNovember 24, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.